Cargando…
Why will it never be known if convalescent plasma is effective for COVID-19
High expectations have been set around convalescent plasma (CP) for the treatment of COVID-19. However, none of the randomized controlled trials (RCTs) conducted so far have reached their primary endpoints. Herein we report that RCTs of CP disclose a high methodological variability in inclusion crit...
Autores principales: | Rojas, Manuel, Anaya, Juan-Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641519/ https://www.ncbi.nlm.nih.gov/pubmed/33169114 http://dx.doi.org/10.1016/j.jtauto.2020.100069 |
Ejemplares similares
-
Convalescent plasma in Covid-19: Possible mechanisms of action
por: Rojas, Manuel, et al.
Publicado: (2020) -
COVID-19 convalescent plasma composition and immunological effects in severe patients
por: Acosta-Ampudia, Yeny, et al.
Publicado: (2021) -
Why should we use convalescent plasma for COVID-19?
por: Franchini, Massimo
Publicado: (2020) -
Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020) -
Convalescent Plasma for the Treatment of Severe COVID-19
por: Franchini, Massimo, et al.
Publicado: (2021)